Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126776011 | 12677601 | 1 | I | 20160704 | 20160817 | 20160823 | 20160823 | EXP | IT-PFIZER INC-2016393279 | PFIZER | 75.00 | YR | M | Y | 0.00000 | 20160823 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126776011 | 12677601 | 1 | PS | Zyvoxid | LINEZOLID | 1 | Intravenous (not otherwise specified) | 1200 MG, DAILY | 21131 | 1200 | MG | ||||||||
| 126776011 | 12677601 | 2 | SS | Zyvoxid | LINEZOLID | 1 | 21131 | ||||||||||||
| 126776011 | 12677601 | 3 | SS | LEVOXACIN | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 1000 MG, DAILY | Y | 0 | 1000 | MG | |||||||
| 126776011 | 12677601 | 4 | SS | LEVOXACIN | LEVOFLOXACIN | 1 | Y | 0 | |||||||||||
| 126776011 | 12677601 | 5 | SS | DECADRON | DEXAMETHASONE | 1 | Intravenous (not otherwise specified) | 12 MG, DAILY | Y | 0 | 12 | MG | |||||||
| 126776011 | 12677601 | 6 | SS | MERREM | MEROPENEM | 1 | Intravenous (not otherwise specified) | 2 G/100 ML, 3X/DAY | Y | 0 | TID | ||||||||
| 126776011 | 12677601 | 7 | C | FLUIMUCIL | ACETYLCYSTEINE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126776011 | 12677601 | 8 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | Subcutaneous | 4000 IU, UNK | 0 | 4000 | IU | ||||||||
| 126776011 | 12677601 | 9 | C | ANTRA /00661201/ | OMEPRAZOLE | 1 | Intravenous (not otherwise specified) | 80 MG, UNK | 0 | 80 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126776011 | 12677601 | 1 | Post procedural infection |
| 126776011 | 12677601 | 2 | Meningitis |
| 126776011 | 12677601 | 3 | Post procedural infection |
| 126776011 | 12677601 | 4 | Meningitis |
| 126776011 | 12677601 | 5 | Oedema |
| 126776011 | 12677601 | 6 | Bacterial infection |
| 126776011 | 12677601 | 7 | Increased upper airway secretion |
| 126776011 | 12677601 | 8 | Thrombosis prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126776011 | 12677601 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126776011 | 12677601 | Gamma-glutamyltransferase increased | |
| 126776011 | 12677601 | Hyperamylasaemia | |
| 126776011 | 12677601 | Hyperbilirubinaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126776011 | 12677601 | 1 | 20160628 | 20160729 | 0 | |
| 126776011 | 12677601 | 3 | 20160629 | 20160706 | 0 | |
| 126776011 | 12677601 | 5 | 20160628 | 20160706 | 0 | |
| 126776011 | 12677601 | 6 | 20160628 | 20160706 | 0 |